title: Human immunodeficiency virus-associated psoriasis and psoriatic arthritis treated with infliximab.
authors.forename: U
authors.initials: U
authors.lastname: Bartke
authors.forename: I
authors.initials: I
authors.lastname: Venten
authors.forename: A
authors.initials: A
authors.lastname: Kreuter
authors.forename: S
authors.initials: S
authors.lastname: Gubbay
authors.forename: P
authors.initials: P
authors.lastname: Altmeyer
authors.forename: N H
authors.initials: NH
authors.lastname: Brockmeyer
authors.forename: S
authors.initials: S
authors.lastname: Gabbay
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D015535:Arthritis, Psoriatic / Q000188:drug therapy; D003879:Dermatologic Agents / Q000627:therapeutic use*; D006679:HIV Seropositivity / Q000150:complications*; D015497:HIV-1 / Q000276:immunology; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D003879:Dermatologic Agents; D000069285:Infliximab